Comprehensive genetic testing identifies targetable genomic alterations in most patients with non-small cell lung cancer, specifically adenocarcinoma, single institute investigation
全面的基因检测可以识别出大多数非小细胞肺癌患者（特别是腺癌患者）体内可靶向的基因组改变，这是一项单中心研究的结果。
期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.7739
Vigneswaran, Janani; Tan, Yi-Hung Carol; Murgu, Septimiu D; Won, Brian M; Patton, Kathryn Alexa; Villaflor, Victoria M; Hoffman, Philip C; Hensing, Thomas; Hogarth, D Kyle; Malik, Renuka; MacMahon, Heber; Mueller, Jeffrey; Simon, Cassie A; Vigneswaran, Wickii T; Wigfield, Christopher H; Ferguson, Mark K; Husain, Aliya N; Vokes, Everett E; Salgia, Ravi
